The effect of baclofen combined with a proton pump inhibitor in patients with refractory laryngopharyngeal reflux: A prospective, open-label study in thirty-two patients

Clin Otolaryngol. 2019 May;44(3):431-434. doi: 10.1111/coa.13297. Epub 2019 Feb 28.

Authors

Young Chan Lee¹, A Ra Jung¹, Oh Eun Kwon¹, Jeong Wook Kang¹, Jin Hyuk Huh¹, Young-Gyu Eun¹

Affiliation

¹ Department of Otolaryngology-Head & Neck Surgery, School of Medicine, Kyung Hee University, Seoul, Korea.

PMID: 30703288
DOI: 10.1111/coa.13297

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Baclofen / therapeutic use*
Drug Therapy, Combination
Esophageal pH Monitoring
Female
Humans
Lansoprazole / therapeutic use*
Laryngopharyngeal Reflux / drug therapy*
Male
Middle Aged
Muscle Relaxants, Central / therapeutic use*
Prospective Studies
Proton Pump Inhibitors / therapeutic use*
Quality of Life

Substances

Muscle Relaxants, Central
Proton Pump Inhibitors
Lansoprazole
Baclofen